NCT06459232View on ClinicalTrials.gov

Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

December 17, 2021

Study Completion Date

December 17, 2021

Conditions
Multiple Sclerosis
Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY